Home Nav
Nextech Invest Logo

Kristina Kakalacheva

Alfred Scheidegger

Prior to joining Nextech in 2014, Dr Kakalacheva developed scientific expertise in immuno-oncology through various research projects. She holds a PhD from the University of Zurich, Switzerland where she researched virus-associated malignancies and led an academia-based drug discovery project. She completed a MSc in integrated immunology from the University of Oxford, UK. During these studies, she performed research at the Jenner Institute for Vaccine Design and the Wellcome Trust Center for Human Genetics in Oxford, UK.


Boston CEO Conference

30.05. – 31.05.2017


  • 25.05.2017

    TRACON announces clinical data presentations at upcoming...

  • 24.05.2017

    TRACON Pharmaceuticals doses first patient in Phase...

  • 17.05.2017

    Jounce Therapeutics to present Phase 1 data from JTX-2011...


Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.


* Compulsory fields


Newsletter Registration

Your eMail have been successfully registered.